Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Sep 3;12:1697–1703. doi: 10.2147/DMSO.S216455

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Li et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

AC3 and hormone-sensitive lipase (HSL) expression at the mRNA level in the liver after treatment with liraglutide or saline. Values are means ± SD (n=6 per group). A 2×2 factorial analysis was used to analyse differences. Panels (A) and (B) present the levels of AC3 mRNA and HSL mRNA, respectively, in the liver tissues of mice after treatment with liraglutide or saline. The P-value of the interaction between obesity and liraglutide treatment for AC3 mRNA and HSL mRNA levels in the livers are 0.030 and 0.958, respectively.

Notes: Between saline and liraglutide, **p<0.01; between normal and obese, ^##p<0.01.